Literature DB >> 21954053

The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction.

Ravi Korabathina1, Kevin S Heffernan, Vikram Paruchuri, Ayan R Patel, James O Mudd, Jordan M Prutkin, Nicole M Orr, Andrew Weintraub, Carey D Kimmelstiel, Navin K Kapur.   

Abstract

BACKGROUND: Right ventricular dysfunction (RVD) is a major cause of morbidity and mortality in the setting of acute inferior wall myocardial infarction (IWMI), and early detection may improve clinical outcomes. We defined a novel hemodynamic index, the pulmonary artery pulsatility index (PAPi), and explored whether the PAPi correlates with severe RVD in acute IWMI.
METHODS: From 2008 to 2010, we identified 20 patients presenting with angiographically confirmed proximal right coronary artery occlusion and suspected RVD (sRVD) as defined by hemodynamic instability, profound bradycardia, or ST-elevation in lead V4R. Two controls groups were studied (1) 50 patients with nonobstructive coronary artery disease (Non-CAD) and (2) 14 patients presenting with acute coronary syndrome requiring left coronary stenting (ACS). Hemodynamic indices analyzed at the time of catheterization included: (1) the right atrial to pulmonary capillary wedge pressure ratio (RA:PCWP), (2) right ventricular stroke work (RVSW), and (3) the PAPi. Qualitative echocardiographic scores of RV systolic function were determined by two blinded investigators within 24 hr of catheterization.
RESULTS: Among subjects with sRVD, 7 (35%) received a percutaneous RV support device (pRVSD) for medically refractory RV failure and 4 (20%) died prior to hospital discharge. Compared to Non-CAD and ACS controls, subjects with sRVD had a significantly lower PAPi (4.32 ± 3.04 vs. 5.52 ± 4.40 vs. 1.11 ± 0.57, respectively, P < 0.01) and a higher RA:PCWP ratio (0.48 ± 0.24 vs. 0.51 ± 0.26 vs. 0.81 ± 0.30, respectively, P < 0.05). Both the PAPi and RA:PCWP ratios correlated significantly with RVSW and qualitative echocardiographic grading. The PAPi demonstrated the highest sensitivity (88.9%) and specificity (98.3%) for predicting in-hospital mortality and/or requirement of a pRVSD. Using ROC curve derived cut-points, a PAPi ≤ 0.9 provided 100.0% sensitivity and 98.3% specificity (C-statistic: 0.998) for predicting these outcomes, exceeding the predictive value of the RA:PCWP ratio or RVSW.
CONCLUSIONS: The PAPi is a simple, invasive hemodynamic measure that may help identify high-risk patients with acute IWMI with severe RVD. Earlier identification of this high-risk population may improve clinical outcomes.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 21954053     DOI: 10.1002/ccd.23309

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  27 in total

Review 1.  Novel Insights and Treatment Strategies for Right Heart Failure.

Authors:  Weiqin Lin; Ai-Ling Poh; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 2.  'Combat' Approach to Cardiogenic Shock.

Authors:  Alexander G Truesdell; Behnam Tehrani; Ramesh Singh; Shashank Desai; Patricia Saulino; Scott Barnett; Stephen Lavanier; Charles Murphy
Journal:  Interv Cardiol       Date:  2018-05

3.  Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock.

Authors:  Justin A Fried; Abhinav Nair; Koji Takeda; Kevin Clerkin; Veli K Topkara; Amirali Masoumi; Melana Yuzefpolskaya; Hiroo Takayama; Yoshifumi Naka; Daniel Burkhoff; Ajay Kirtane; Dimitrios Karmpaliotis; Jeffrey Moses; Paolo C Colombo; A Reshad Garan
Journal:  J Heart Lung Transplant       Date:  2018-03-20       Impact factor: 10.247

Review 4.  Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension.

Authors:  Rupa K Patil; Parag Goyal; Rajesh V Swaminathan; Luke K Kim; Dmitriy N Feldman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

5.  Association of Pulmonary Artery Pulsatility Index With Adverse Cardiovascular Events Across a Hospital-Based Sample.

Authors:  Emily K Zern; Dongyu Wang; Paula Rambarat; Samuel Bernard; Samantha M Paniagua; Elizabeth E Liu; Jenna McNeill; Jessica K Wang; Carl T Andrews; Eugene V Pomerantsev; Michael H Picard; Jennifer E Ho
Journal:  Circ Heart Fail       Date:  2022-02-09       Impact factor: 8.790

6.  Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.

Authors:  Sula Mazimba; Timothy S Welch; Hunter Mwansa; Khadijah K Breathett; Jamie L W Kennedy; Andrew D Mihalek; William C Harding; Manu M Mysore; David X Zhuo; Kenneth C Bilchick
Journal:  Heart Lung Circ       Date:  2018-04-17       Impact factor: 2.975

Review 7.  A right ventricular state of mind in the progression of heart failure with reduced ejection fraction: implications for left ventricular assist device therapy.

Authors:  Ersilia M DeFilippis; Marco Guazzi; Paolo C Colombo; Melana Yuzefpolskaya
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

8.  Successful resuscitation of acute cardiogenic shock presenting as ventricular fibrillation via Bipella approach: a case report.

Authors:  Dominika M Zoltowska; Yashwant Agrawal; Jean-Yves R Nazroo; Kirit Patel
Journal:  Eur Heart J Case Rep       Date:  2021-02-11

9.  Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices.

Authors:  Alaide Chieffo; Dariusz Dudek; Christian Hassager; Alain Combes; Mario Gramegna; Sigrun Halvorsen; Kurt Huber; Vijay Kunadian; Jiri Maly; Jacob Eifer Møller; Federico Pappalardo; Giuseppe Tarantini; Guido Tavazzi; Holger Thiele; Christophe Vandenbriele; Nicolas van Mieghem; Pascal Vranckx; Nikos Werner; Susanna Price
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2021-06-30

10.  Exercise right ventricular ejection fraction predicts right ventricular contractile reserve.

Authors:  Catherine G Ireland; Rachel L Damico; Todd M Kolb; Stephen C Mathai; Monica Mukherjee; Stefan L Zimmerman; Ami A Shah; Fredrick M Wigley; Brian A Houston; Paul M Hassoun; David A Kass; Ryan J Tedford; Steven Hsu
Journal:  J Heart Lung Transplant       Date:  2021-02-17       Impact factor: 13.569

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.